DRUG: Hyaluronidase Help Entry D04456                      Drug                                    Name Hyaluronidase (JAN/INN); Amphadase (TN) Product AMPHADASE (Amphastar Pharmaceuticals) Remark ATC code:  B06AA03 Chemical structure group:  DG00190 Product (DG00190):  D04455<US> D04456<US> D06604<US> Product (mixture):  D11967<JP/US> Efficacy Adjuvant (spreading) Comment Hyaluronidase [KO:K01197] [EC:3.2.1.35] Brite Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]  B BLOOD AND BLOOD FORMING ORGANS   B06 OTHER HEMATOLOGICAL AGENTS    B06A OTHER HEMATOLOGICAL AGENTS     B06AA Enzymes      B06AA03 Hyaluronidase       D04456  Hyaluronidase (JAN/INN) <US> New drug approvals in the USA [br08319.html]  New molecular entities and new therapeutic biological products   D04456 New drug approvals in the USA, Europe and Japan [br08328.html]  Approval dates by FDA, EMA and PMDA   D04456 BRITE hierarchy Other DBs CAS:  9001-54-1 PubChem:  47206321 NIKKAJI:  J209.195J LinkDB All DBs » Japanese version   » Back

DBGET integrated database retrieval system